Skip to main content
Retour
Watch Compare

CANNAPHARMARX, INC.

Qualité des données : 100%
CPMD
OTC Manufacturing Chemicals
0,00 €
▼ 0,00 € (-25,00%)
Cap. Boursière: 2,71 M
Prix
0,00 €
Cap. Boursière
2,71 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -794 621,0
Capital efficient — spends only 0,41% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)66,09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-817,19%
Op. Margin-245,77%

Sécurité

Debt / Equity
N/A
Current Ratio0,05
Interest Coverage-1,71

Valorisation

PE (TTM)
-0,24
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -0,2 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -817,2 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) 66,09% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,36 M Net Income (TTM) -11,13 M
ROE N/A ROA -96,42%
Gross Margin -153,06% Operating Margin -245,77%
Net Margin -817,19% Free Cash Flow (TTM) -794 621,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,05
Interest Coverage -1,71 Asset Turnover 0,12
Working Capital -27,01 M Tangible Book Value -22,52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,24 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,99
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -29,28%
Market Cap 2,71 M Enterprise Value 2,71 M
Per Share
EPS (Diluted TTM) -0,02 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,41% FCF Conversion 7,14%
SBC-Adj. FCF -794 621 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Revenue 1,36 M 820 137,0 0,0 0,0 0,0
Net Income -11,13 M -9,91 M -8,53 M -8,83 M -19,89 M
EPS (Diluted) -0,02 -0,02 0,04 — —
Gross Profit -2,08 M -2,93 M — — —
Operating Income -3,35 M -3,61 M -5,21 M -2,99 M -14,49 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — 116 640,0 — — —
D&A — 0,0 294 934,0 2 708,0 128 505,0
Interest Expense 1,96 M 2,26 M 2,29 M 1,51 M 2,29 M
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Total Assets 7,02 M 10,84 M 5,41 M 114 330,0 8,75 M
Total Liabilities 37,17 M 30,65 M 22,76 M 13,04 M 17,55 M
Shareholders' Equity -30,15 M -19,81 M -17,34 M -12,93 M -8,80 M
Total Debt — — — — —
Cash & Equivalents 1 804,0 2 156,0 2 317,0 27 767,0 334 969,0
Current Assets 1,31 M 1,02 M 100 014,0 29 538,0 467 551,0
Current Liabilities 31,59 M 25,75 M 17,17 M 13,04 M 17,55 M